Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar;27(3):796-805.
doi: 10.1007/s10461-022-03812-4. Epub 2022 Sep 12.

Examining HIV Diagnosis and Linkage to PrEP Prescription Among Members at An Integrated Health System in the Southeast United States

Affiliations

Examining HIV Diagnosis and Linkage to PrEP Prescription Among Members at An Integrated Health System in the Southeast United States

Teaniese L Davis et al. AIDS Behav. 2023 Mar.

Abstract

Pre-Exposure Prophylaxis (PrEP) is a priority method for preventing HIV infection. This study's aims were threefold: (1) identify characteristics of members of a large health maintenance organization, Kaiser Permanente Georgia (KPGA), associated with HIV infection, (2) identify which member characteristics associated with HIV were also associated with PrEP prescription, and (3) identify which HIV-associated characteristics were associated with under- or over-prescribing of PrEP. Analysis of variables from the electronic medical record revealed that age, race, gender, mental health diagnosis, STI diagnosis, and sexual orientation were independently associated with HIV diagnosis. The same characteristics were independently associated with PrEP prescription except for race. Persons identifying as Black or unknown race, women, and/or heterosexual; and who had an STI diagnosis and/or illicit drug use had lower odds of being prescribed PrEP than of having an HIV diagnosis. The implications of these findings for improving physician identification of candidates for PrEP prescription are discussed.

Keywords: HIV; Pre-Exposure Prophylaxis (PrEP); Prescription; Prevention; Providers.

PubMed Disclaimer

Similar articles

References

    1. CDC. Pre-Exposure P, Atlanta. GA: U.S. Department of Health & Human Services; 2018 [Available at: https://www.cdc.gov/hiv/risk/prep/index.html .] Accessed August 4, 2022.
    1. Tanner MR, Miele P, Carter W, et al. Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents: Clinical Considerations, 2020. MMWR Recomm Rep 2020;69(No. RR-3):1–12. DOI: https://doi.org/10.15585/mmwr.rr6903a1 .
    1. FDA approves second drug to. prevent HIV infection as part of ongoing efforts to end the HIV epidemic [press release]. Food and Drug Administration, 2019.[Available at: https://www.fda.gov/news-events/press-announcements/fda-approves-second-... .] Access August 4, 2022.
    1. CDC. PrEP Effectiveness. [Available at: https://www.cdc.gov/hiv/basics/prep/prep-effectiveness.html .] Accessed on August 4, 2022.
    1. Surveillance CDCHIV, Report. 2018 (Updated). MMWR. 2020;Vol.31. [Available at: https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveil... .] Accessed on August 4, 2022.

Substances

LinkOut - more resources